Buchang subsidiary passes GMP inspection, receives new drug approval

Shandong Buchang Pharmaceutical Co., Ltd. [SSE:603858] announced that its holding subsidiary, Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd., has passed a GMP compliance inspection by the Sichuan Provincial Drug Administration. The inspection covered the production lines for therapeutic biological products, specifically injection of Epoetin alfa, across two workshops. The conclusion confirms compliance with the "Good Manufacturing Practice for Pharmaceutical Products" (2010 revision) and its appendices.